Welch & Forbes LLC Zimmer Biomet Holdings, Inc. Transaction History

Welch & Forbes LLC

$8.21 Billion
Q3 2025

A detailed history of Welch & Forbes LLC transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Welch & Forbes LLC holds 9,244 shares of ZBH stock, worth $831,128. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,244

Previous 9,444 2.12%

Holding current value

$831,128

Previous $861,000 5.69%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	SELL	$90.62 - $107.71 $18,124 - $21,542	-200 Reduced 2.12%	9,244 $910,000
Q2 2025 Aug 04, 2025	SELL	$90.21 - $112.66 $4,510 - $5,633	-50 Reduced 0.53%	9,444 $861,000
Q1 2025 May 02, 2025	SELL	$98.98 - $113.18 $103,533 - $118,386	-1,046 Reduced 9.92%	9,494 $1.07 Million
Q4 2024 Feb 06, 2025	SELL	$101.77 - $113.02 $23,712 - $26,333	-233 Reduced 2.16%	10,540 $1.11 Million
Q3 2024 Nov 04, 2024	SELL	$104.47 - $116.17 $80,964 - $90,031	-775 Reduced 6.71%	10,773 $1.16 Million

Q2 2024 Aug 01, 2024	SELL	$106.25 - $130.01 $53,125 - $65,004	-500 Reduced 4.15%	11,548 $1.25 Million
Q1 2024 May 02, 2024	SELL	$119.98 - $132.61 $122,859 - $135,792	-1,024 Reduced 7.83%	12,048 $1.59 Million
Q4 2023 Feb 06, 2024	SELL	$102.72 - $121.7 $159,113 - $188,513	-1,549 Reduced 10.59%	13,072 $1.59 Million
Q3 2023 Nov 02, 2023	SELL	$110.76 - $143.18 $87,278 - $112,825	-788 Reduced 5.11%	14,621 $1.64 Million
Q2 2023 Jul 28, 2023	BUY	$126.43 - $145.6 $48,422 - $55,764	383 Added 2.55%	15,409 $2.24 Million
Q4 2022 Feb 02, 2023	BUY	$104.7 - $128.4 $57,270 - $70,234	547 Added 3.78%	15,026 $1.92 Million
Q3 2022 Oct 28, 2022	SELL	$101.65 - $119.27 $69,630 - $81,699	-685 Reduced 4.52%	14,479 $1.51 Million
Q2 2022 Jul 22, 2022	SELL	$102.23 - $133.85 $30,669 - $40,155	-300 Reduced 1.94%	15,164 $1.59 Million
Q1 2022 Apr 25, 2022	SELL	$108.42 - $129.58 $22,768 - $27,211	-210 Reduced 1.34%	15,464 $1.98 Million
Q4 2021 Jan 19, 2022	SELL	$115.43 - $146.63 $69,258 - $87,978	-600 Reduced 3.69%	15,674 $1.99 Million
Q3 2021 Oct 13, 2021	SELL	$136.35 - $158.76 $100,080 - $116,529	-734 Reduced 4.32%	16,274 $2.38 Million
Q2 2021 Jul 22, 2021	SELL	$152.95 - $173.41 $9,177 - $10,404	-60 Reduced 0.35%	17,008 $2.74 Million
Q1 2021 Apr 14, 2021	SELL	$148.16 - $159.71 $35,558 - $38,330	-240 Reduced 1.39%	17,068 $2.73 Million
Q4 2020 Jan 20, 2021	SELL	$128.25 - $151.41 $99,393 - $117,342	-775 Reduced 4.29%	17,308 $2.67 Million
Q3 2020 Oct 23, 2020	SELL	$113.59 - $141.68 $88,032 - $109,802	-775 Reduced 4.11%	18,083 $2.46 Million
Q2 2020 Jul 15, 2020	SELL	$87.02 - $133.4 $210,762 - $323,094	-2,422 Reduced 11.38%	18,858 $2.25 Million
Q1 2020 Apr 17, 2020	SELL	$78.28 - $155.73 $281,808 - $560,628	-3,600 Reduced 14.47%	21,280 $2.15 Million
Q4 2019 Jan 17, 2020	SELL	$127.4 - $146.83 $90,963 - $104,836	-714 Reduced 2.79%	24,880 $3.72 Million
Q3 2019 Oct 11, 2019	SELL	$113.33 - $138.46 $29,919 - $36,553	-264 Reduced 1.02%	25,594 $3.51 Million
Q2 2019 Jul 12, 2019	SELL	$108.87 - $125.09 $153,180 - $176,001	-1,407 Reduced 5.16%	25,858 $3.04 Million
Q1 2019 Apr 29, 2019	SELL	$97.5 - $125.79 $270,562 - $349,067	-2,775 Reduced 9.24%	27,265 $3.48 Million
Q3 2018 Oct 17, 2018	SELL	$108.41 - $127.64 $149,931 - $176,526	-1,383 Reduced 4.4%	30,040 $3.95 Million
Q2 2018 Jul 16, 2018	SELL	$102.12 - $114.04 $316,674 - $353,638	-3,101 Reduced 8.98%	31,423 $3.5 Million
Q1 2018 Apr 12, 2018	SELL	$104.31 - $124.46 $205,073 - $244,688	-1,966 Reduced 5.39%	34,524 $3.77 Million
Q4 2017 Jan 26, 2018	SELL	$105.55 - $120.83 $573,242 - $656,227	-5,431 Reduced 12.96%	36,490 $4.4 Million
Q3 2017 Nov 13, 2017	BUY	$106.92 - $117.79 $4.48 Million - $4.94 Million	41,921	41,921 $4.91 Million

Others Institutions Holding ZBH

# of Institutions

1,104

Shares Held

195M

Call Options Held

242K

Put Options Held

464K

View Full List

About ZIMMER BIOMET HOLDINGS, INC.

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $18.9B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

More about ZBH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch & Forbes LLC with notifications on news.

Account